Jacqualyn A. Fouse

2019 - Agios Pharmaceuticals

In 2019, Jacqualyn A. Fouse earned a total compensation of $16.6M as Chief Executive Officer at Agios Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$424,125
Option Awards$12,875,608
Salary$664,583
Stock Awards$2,538,474
Other$105,204
Total$16,607,994

Fouse received $12.9M in option awards, accounting for 78% of the total pay in 2019.

Fouse also received $424.1K in non-equity incentive plan, $664.6K in salary, $2.5M in stock awards and $105.2K in other compensation.

Rankings

In 2019, Jacqualyn A. Fouse's compensation ranked 273rd out of 13,971 executives tracked by ExecPay. In other words, Fouse earned more than 98.0% of executives.

ClassificationRankingPercentile
All
273
out of 13,971
98th
Division
Manufacturing
96
out of 5,701
98th
Major group
Chemicals And Allied Products
25
out of 2,200
99th
Industry group
Drugs
21
out of 1,886
99th
Industry
Pharmaceutical Preparations
18
out of 1,398
99th

Pay ratio

Jacqualyn A. Fouse's Pay$16,607,994
Median Employee's Pay$267,104
Pay Ratio

62

to 1

In 2019, the annual total compensation of Jacqualyn A. Fouse was $16,607,994.

The annual total compensation of the median employee at Agios Pharmaceuticals was $267,104.

The ratio of Jacqualyn A. Fouse's pay to the pay of median employee was therefore 62 to one.

Source: SEC filing on April 16, 2020.

Fouse's colleagues

We found five more compensation records of executives who worked with Jacqualyn A. Fouse at Agios Pharmaceuticals in 2019.

2019

Andrew Hirsch

Agios Pharmaceuticals

Chief Financial Officer

2019

Christopher Bowden

Agios Pharmaceuticals

Chief Medical Officer

2019

Scott Biller

Agios Pharmaceuticals

Chief Scientific Officer

2019

Jonathan Biller

Agios Pharmaceuticals

Chief Legal Officer

2019

David Schenkein

Agios Pharmaceuticals

Chief Executive Officer

News

In-depth

You may also like